在慢性心力衰竭患者中重新定义铁缺乏症
Milton Packer1,2, Stefan D Anker3, Javed Butler4,1,5
1Baylor University Medical Center (M.P.), Dallas, TX.
Circulation
|May 11, 2024
概括
目前基于费里的铁缺乏症定义是不可靠的. 更准确的方法是使用转激素和率 (TSAT) < 20% 来识别受益于铁治疗的患者.
科学领域:
- 心脏病学
- 血液学
- 内部医学
背景情况:
- 在慢性病和由于炎症而导致的心力衰竭的患者中,传统的血清费里丁值对识别铁缺乏不准确.
- 目前针对心力衰竭的铁缺乏症的指导方针,基于铁素水平升高,误判患者并不能可靠地预测铁治疗的反应.
- 尼普利辛和-葡萄糖携带体2抑制剂等药物可以进一步扭曲血清费里水平.
研究的目的:
- 评估目前铁缺乏症在心力衰竭中的有效性.
- 提出一种基于证据的替代性铁缺乏症定义.
- 通过转林和 (TSAT) <20%来确定低血是铁缺乏症和对铁疗法的反应更可靠的标志物.
主要方法:
- 关于缺铁的定义和心力衰竭治疗结果的现有文献和临床试验数据的审查.
- 通过骨髓检查确认血清费里与TSAT的诊断准确性.
- 根据不同铁缺乏症定义,评估铁治疗对功能能力和心血管结果的影响.
主要成果:
- 目前基于费里的定义不准确地包括没有缺铁的患者,不包括那些从铁中受益的人.
- 通过骨髓检查证实,TSAT < 20% (低血症) 可靠地识别出患有铁缺乏症的患者.
- 静脉注射铁疗法改善了运动耐受性,并将心血管死亡或心力衰竭住院率降低了20% - 30%.
结论:
- 应该放弃铁素驱动的铁缺乏症的定义.
- 基于低铁血症 (TSAT < 20%) 的定义是基于证据的,并且在临床上更有意义,用于识别受益于铁疗法的心力衰竭患者.
- 采用TSAT<20%的值可以优化补充铁的策略,并改善心力衰竭患者的结果.
相关概念视频
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
Heart Failure Drugs: Diuretics
367
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
367
Heart Failure Drugs: Inotropic Agents
573
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
573
Heart Failure Drugs: β-Blockers
337
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
337
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K


